Stay updated on CPIT001 Clinical Trial

Sign up to get notified when there's something new on the CPIT001 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CPIT001 Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.0%
    Check dated 2024-06-13T23:15:55.000Z thumbnail image
  4. Check
    3 days ago
    No Change Detected
  5. Check
    4 days ago
    No Change Detected
  6. Check
    6 days ago
    Change Detected
    Summary
    The value of the publication has been updated to include a new erratum reference in the citation for Wolchok JD, Kluger H, Callahan MK, Postow MA, Rizvi NA, Lesokhin AM, Segal NH, Ariyan CE, Gordon RA, Reed K, Burke MM, Caldwell A, Kronenberg SA, Agunwamba BU, Zhang X, Lowy I, Inzunza HD, Feely W, Horak CE, Hong Q, Korman AJ, Wigginton JM, Gupta A, Sznol M. Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2013 Jul 11;369(2):122-33. doi: 10.1056/NEJMoa1302369. Epub 2013 Jun 2. Erratum In: N Engl J Med. 2018 Nov 29;379(22):2185. doi: 10.1056/NEJMx180040.
    Difference
    0.0%
    Check dated 2024-06-10T20:22:05.000Z thumbnail image
  7. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage. This change likely represents an update or correction in the data related to a study on combined checkpoint inhibition after autologous hematopoietic stem cell transplantation in patients at high risk for post-transplant recurrence, focusing on safety, clinical effects, adverse events, immune reconstitution, and gut microbiome analysis.
    Difference
    0.0%
    Check dated 2024-06-06T14:51:00.000Z thumbnail image
  8. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to include detailed eligibility criteria for participants, specifying that researchers are looking for individuals who meet certain health conditions and prior treatment histories. The new criteria also outline specific inclusion and exclusion conditions for participants, such as age range, health status, and specific disease characteristics.
    Difference
    34%
    Check dated 2024-05-22T21:29:18.000Z thumbnail image
  9. Check
    46 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2024-04-30T22:48:55.000Z thumbnail image

Stay in the know with updates to CPIT001 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CPIT001 Clinical Trial page.